Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: Study protocol for a randomised controlled trial

Trials

Volumn 17, Issue 1, 2016, Pages

  Popplewell, Matthew A ^a   Davies, Huw ^a   Jarrett, Hugh ^b   Bate, Gareth ^a   Grant, Margaret ^b   Patel, Smitaa ^b   Mehta, Samir ^b   Andronis, Lazaros ^b   Roberts, Tracy ^b   Deeks, Jon ^b   Bradbury, Andrew ^a  

^a SOLIHULL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Amputation; Angioplasty; Bypass surgery; Critical limb ischaemia; Diabetes; Endovascular treatment; Severe limb ischaemia; Stent

Indexed keywords

ADULT; AGED; AMPUTATION FREE SURVIVAL; ANGIOPLASTY; ARTICLE; BYPASS SURGERY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FOOT AMPUTATION; HUMAN; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PILOT STUDY; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; UNITED KINGDOM; VERY ELDERLY; CLINICAL PROTOCOL; COMPARATIVE STUDY; ENDOVASCULAR SURGERY; ISCHEMIA; LEG; PROCEDURES; SAMPLE SIZE; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY; CLINICAL PROTOCOLS; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; SAMPLE SIZE;

EID: 84953321837     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-1114-2     Document Type: Article

References (12)

1. Norgen L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75.
2. Varu VN, Hogg ME, Kibbe MR. Critical Limb Ischaemia. J Vasc Surg. 2010;51:230-41.
3. National Health Service Choices: Amputation. [ http://www.nhs.uk/conditions/amputation ]. Accessed 23/12/15.
4. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925-34.
5. National Institute for Health and Care Excellence (NICE). Clinical Guideline 147: Peripheral Arterial Disease. Available from: https://www.nice.org.uk/guidance/cg147. Accessed 23/12/15.
6. Mills JL, Conte MS, Armstrong DG, Pomposeli FB, Schanzer A, Sidawy AN, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischaemia, and foot infection (WIfI). J Vasc Surg. 2014;59:220-34.
7. Karthikesalingam A, Holt PJE, Moxey P, Jones KG, Thompson MM, Hinchliffe RJ. A systematic review of scoring systems for diabetic foot ulcers. Diabet Med. 2010;27:544-9.
8. Medicines and Healthcare Products Regulatory Agency: Good Clinical Practice. 2014. Available from: http://www.mhra.gov.uk/Howweregulate/Medicines/Inspectionandstandards/GoodClinicalPractice. Accessed 23/12/15.
9. nd edition. London, UK: Department of Health; 2005.
10. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5 L). Qual Life Res. 2011;20:1727-36.
11. van Hout B, Janssen M, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5 L: Mapping the EQ-5D-5 L to EQ-5D-3 L value sets. Value Health. 2012;15:708-15.
12. Andronis L, Barton P, Bryan S. Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. Health Technol Assess. 2009;13:1-61.